Insider · CIK 0001724253
Angelos M. Stergiou
Files at SLS (SELLAS Life Sciences Group, Inc.). First filing -, latest -.
Angelos M. Stergiou files SEC Form 4 as CEO, president and director at SLS (SELLAS Life Sciences Group, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Angelos M. Stergiou has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | SLS SELLAS Life Sciences Group, Inc. | AGrant or award Common Stock | +1,065,000 | $0.00 | $0 | 1,759,183 | Jun 18, 2026 |
| Dec 3, 2025 | SLS SELLAS Life Sciences Group, Inc. | JOther Common Stock | -187,066 | $1.50 | $281k | 686,966 | Dec 5, 2025 |
| Dec 4, 2024 | SLS SELLAS Life Sciences Group, Inc. | JOther Common Stock | -28,289 | $1.13 | $32k | 358,132 | Dec 5, 2024 |
Questions about Angelos M. Stergiou
Answered from the filings on this page, as of the latest one.
Is Angelos M. Stergiou buying or selling?
Angelos M. Stergiou has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Angelos M. Stergiou's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Angelos M. Stergiou has 0.
Where does Angelos M. Stergiou file Form 4?
Angelos M. Stergiou has filed Form 4 at SLS (SELLAS Life Sciences Group, Inc.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.